Publications by authors named "Marc Scheetz"

Claim this Profile
I
Impact of Remote Cholecystectomy on Clinical Outcomes Following Bloodstream Infection.
Hanna K Bertucci, Lyndsey R Heise, Anne Kurze, Michael P Angarone, Alan R Hauser, Marc H Scheetz

Open Forum Infect Dis· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Piperacillin/tazobactam clearance predicted by non-creatinine based estimates of GFR in critically ill adults.
Erin F Barreto, Jack Chang, Andrew D Rule, Kristin C Cole, Lindsay Fogelson, Marc H Scheetz

Int J Antimicrob Agents· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Population Pharmacokinetic/Toxicodynamic Model for Polymyxin B in Critically Ill Patients to Identify the Risk of Nephrotoxicity.
Patrick O Hanafin, Ramya Mahadevan, Gauri G Rao, Alexandre P Zavascki, Ana Maria Sandri, Marc H Scheetz

Clin Pharmacol Ther· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effectiveness of piperacillin/tazobactam loading dose for extended infusion dosing among patients with Gram-negative bacteraemia.
Savan Patel, Sana Mohayya, Arsheena Yassin, Judy Dao, Emily Aboujaoude, Marc H Scheetz

J Antimicrob Chemother· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Oral Cephalexin Population Pharmacokinetics and Target Attainment Analysis in Infants 7-60 Days Old.
Andrew S Haynes, Zixuan Wei, Marc H Scheetz, Daniel Gonzalez, Kevin Messacar

J Pediatric Infect Dis Soc· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Urinary tract infection in adults: gaps in current guidelines - opinions from an international multidisciplinary panel and relevance to clinical practice.
Kalpana Gupta, Florian Wagenlehner, Mark Wilcox, Sonali D Advani, Manu Bilsen, Marc Scheetz

BMC Proc· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Individual target pharmacokinetic/pharmacodynamic attainment rates among cefepime-treated patients admitted to the ICU with hospital-acquired pneumonia with and without ECMO.
Adrian Valadez, Marta Zurawska, Emma Harlan, Marc H Scheetz, MIchael N Neely

Antimicrob Agents Chemother· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Machine learning model for tacrolimus dosing: Can we validate and compare to existing options?
Michael G S Shashaty, Gary E Weissman, Marc H Scheetz, Todd A Miano

J Heart Lung Transplant· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Response to Cojutti and Pea, "Is it Time to Move From Intermittent to Continuous Infusion Administration of Vancomycin?".
Justin Shiau, Sharmeen Roy, Paul Sabourenkov, Marc H Scheetz

Open Forum Infect Dis· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cystatin C-Guided Dosing Nomogram Improves Target Attainment for Cefepime in the Critically Ill.
Erin F Barreto, Marc H Scheetz, Jack Chang, Kristin C Cole, Lindsay A Fogelson

Crit Care Med· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Big Data Bayesian Truths: No Vancomycin Trough Concentration Target Is Sufficiently Precise for Safety or Efficacy.
Justin Shiau, Sharmeen Roy, Paul Sabourenkov, Marc H Scheetz

Open Forum Infect Dis· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Refined methodology for quantifying virulence using .
Christopher M R Axline, Travis J Kochan, Sophie Nozick, Timothy Ward, Tania Afzal, Marc H Scheetz

Microbiol Spectr· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Protamine protects against vancomycin-induced kidney injury.
Justin Shiau, Patti Engel, Mark Olsen, Gwendolyn Pais, Jack Chang, Marc H Scheetz

Antimicrob Agents Chemother· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of Pseudonephrotoxicity on Apparent Acute Kidney Injury Incidence and Severity: A Simulation Study.
Todd A Miano, Christina H W Brotman, Marc H Scheetz, Michael G S Shashaty

Clin J Am Soc Nephrol· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Past, present, and future biomarkers of kidney function and injury: The relationship with antibiotics.
Jack Chang, Gwendolyn M Pais, Erin F Barreto, Bryce Young, Haley Scott, Marc H Scheetz

Int J Antimicrob Agents· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development and validation of a population pharmacokinetic model to guide perioperative tacrolimus dosing after lung transplantation.
Todd A Miano, Athena F Zuppa, Rui Feng, Stephen Griffiths, Laurel Kalman, Marc H Scheetz

JHLT Open· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Meta-analysis on safety of standard vs. prolonged infusion of beta-lactams.
Hunter Rolain, Zachary Schwartz, Raymond Jubrail, Kevin J Downes, Lisa Hong, Marc H Scheetz

Int J Antimicrob Agents· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Antimicrobial therapeutic drug monitoring in critically ill adult patients - An international perspective on access, utilisation, and barriers.
Paul Williams, Menino Osbert Cotta, Alexis Tabah, Indy Sandaradura, Salmaan Kanji, Marc H Scheetz

Int J Antimicrob Agents· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of humanized vancomycin infusion on kidney function and kidney injury in a translational rat model.
Jack Chang, Gwendolyn M Pais, Raymond Jubrail, Patti L Engel, Marc H Scheetz

Int J Antimicrob Agents· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cefadroxil and cephalexin pharmacokinetics and pharmacodynamics in children with musculoskeletal infections.
Andrew S Haynes, Zixuan Wei, Peter Anderson, Marc H Scheetz, Sarah K Parker

Antimicrob Agents Chemother· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
In-vitro and in-vivo assessment of nirmatrelvir penetration into CSF, central nervous system cells, tissues, and peripheral blood mononuclear cells.
Sean N Avedissian, Johid R Malik, Anthony T Podany, Michael Neely, Nathaniel J Rhodes, Marc H Scheetz

Sci Rep· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Response to comment on "International consensus recommendations for the use of prolonged-infusion β-lactams endorsed by the American College of Clinical Pharmacy (ACCP), the British Society for Antimicrobial Chemotherapy (BSAC), the Cystic Fibrosis Foundation (CFF), the European Society of Clinical Microbiology and Infectious Diseases (ESCMID), the Infectious Diseases Society of American (IDSA), the Society of Critical Care Medicine (SCCM), and the Society of Infectious Diseases Pharmacists".
Lisa T Hong, Kevin J Downes, Alireza FakhriRavari, Jacinda C Abdul-Mutakabbir, Joseph L Kuti, Marc H Scheetz

Pharmacotherapy· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Bioanalysis of six antibiotics from volumetric microsamples: a new tool for precision dosing in critically ill children.
John Takyi-Williams, Abbie D Leino, Ruiting Li, Kevin J Downes, Athena F Zuppa, Marc H Scheetz

Bioanalysis· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Individual meropenem epithelial lining fluid and plasma PK/PD target attainment.
Roxane Rohani, Paul R Yarnold, Marc H Scheetz, Michael N Neely, Mengjia Kang

Antimicrob Agents Chemother· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of Various Estimated Glomerular Filtration Rate Equations on the Pharmacokinetics of Meropenem in Critically Ill Adults.
Erin F Barreto, Jack Chang, Andrew D Rule, Kristin C Mara, Laurie A Meade, Marc H Scheetz

Crit Care Explor· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis